Treatment of atherosclerotic renovascular disease
MetadataShow full item record
Treatment of atherosclerotic renovascular disease is controversial and revascularization is not a beneficial approach to all patients. Conditions as progressive deterioration of renal function, refractory hypertension or accelerated cardiovascular disease, especially recurrent pulmonary edema, could profit from renal angioplasty with stent placement. Surgical revascularization is a good option for patients who will need concomitant surgical corrections of abdominal aortic lesions. Treatment of all other patients must be individualized. Medical therapy is indicated for all patients with atherosclerotic renovascular disease. Observational studies pointed out to the beneficial effect of controlling blood pressure (<130/80 mm Hg), glucose and lipids profile, lifestyle modifications, specific use of platelet antiaggregant therapy, Angiotensin Conversion Enzyme Inhibitors (ACEI) and statins. All others cardiovascular risk factors must be controlled. The evaluation and management of other systemic atherosclerotic vascular lesions is important, especially coronary, carotid and abdominal aortic. This paper presents a review of evidences to rationale the atherosclerotic renovascular disease treatment. © 2008 Bentham Science Publishers Ltd.
How to cite this document
Showing items related by title, author, creator and subject.
Juvenile localized scleroderma: Clinical and epidemiological features in 750 children. An international study Zulian, F.; Athreya, B. H.; Laxer, R.; Nelson, A. M.; Feitosa de Oliveira, S. K.; Punaro, M. G.; Cuttica, R.; Higgins, G. C.; Van Suijlekom-Smit, L. W A; Moore, T. L. et al. (Rheumatology, 2006) [Artigo]Objective. Juvenile localized scleroderma (JLS) includes a number of conditions often grouped together. With the long-term goal of developing uniform classification criteria, we studied the epidemiological, clinical and ...
Farmacología en la tercera edad: Medicamentos de uso continuo y peligros de la interacción medicamentosa Haddad, Marcela Filié ; Takamiya, Aline Satie ; da Silva, Eulália Maria Martins ; Barbosa, Débora de Barros (Gerokomos, 2009) [Artigo]Introduction: It was observed a considerable growth of elderly people. They are who use more medicines. The physiological changes associated with the age advancing can make pharmacokinetic and pharmacodynamic alterations. ...
Influence of TNF-α blockers on the oral prevalence of opportunistic microorganisms in ankylosing spondylitis patients Pereira, D. F A ; Pinheiro, M. M.; Silva, P. N F ; Teodoro, G. R. ; Brighenti, Fernanda Lourenção ; Koga-Ito, C. Y. (Clinical and Experimental Rheumatology, 2012) [Artigo]Objectives: To compare the oral prevalence and antimicrobial susceptibility of Candida spp., staphylococci, enterobacteriaceae, and pseudomonas spp.from ankylosing spondylitis (AS) patients receiving conventional and ...